The high expression of DNMT1 in tumor cells was previously linked to the binding of MYC to the DNMT1 promoter region and subsequent activation of its transcription,[41] where DNMT1 can be further recruited by enhancer of EZH2 to methylate the promoter sequence of tumor suppressors.[42]. The gene discussed is MYC; the disease is neoplasm.